Analytical performances of the newly developed, fully automated Kryptor® Copeptin assay: Which impact factor for myocardial infarction rules out in the emergency department?

Clinical Laboratory

Volumn 58, Issue 7-8, 2012, Pages 635-644

  Dupuy, Anne Marie ^a   Chastang, Elsa ^a   Cristol, Jean Paul ^a   Jreige, Riad ^a   Lefebvre, Sophie ^a   Sebbane, Mustapha ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

Acute coronary syndrome; Cardiac troponin I; Copeptin; Rule out

Indexed keywords

COPEPTIN; MEMBRANE PROTEIN; TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOVASCULAR EQUIPMENT; EMERGENCY WARD; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX PAIN;

CHEST PAIN; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; LIMIT OF DETECTION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 84866139346     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2011.110633     Document Type: Article

References (22)

1. Morgenthaler NG, Struck J, Jochberger S, Dünser MW. Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab 2008 Mar;19(2):43-9.
2. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006 Jan;52(1):112-9.
3. NCCLS. Protocols for Determination of Limits of Detection and Limits of Quantitation; Approved Guideline. NCCLS document EP17-A (ISBN 1-56238-551-8). NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898, USA, 2004.
4. Panteghini M. Assay-related issues in the measurement of cardiac troponins. Clin Chim Acta 2009 Apr;402(1-2):88-93.
5. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Jaffe AS, Apple FS, Galvani M, et al. Universal definition of myocardial infarction. Circulation 2007 Nov 27;116(22):2634-53.
6. Uettwiller-Geiger D, Wu AH, Apple FS, et al. Multicenter evaluation of an automated assay for troponin I. Clin Chem 2002 Jun; 48:869-76.
7. Reichlin T, Hochholzer W, Stelzig C, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 2009 Jun 30;54(1):60-8.
8. Keller T, Tzikas S, Zeller T, et al. Copeptin Improves Early Diagnosis of Acute Myocardial Infarction. J Am Coll Cardiol 2010 Jan 2;55(19):2096-102.
9. Giannitsis E, Kehayova T, Vafaie M, Katus HA. Combined testing of high-sensitivity troponin T and copeptin on presentation at prespecified cutoffs improves rapid rule-out of non-ST-segment elevation myocardial infarction. Clin Chem 2011 Oct;57(10): 1452-5.
10. Meune C, Zuily S, Wahbi K, Claessens YE, Weber S, Chenevier-Gobeaux C. Combination of copeptin and high-sensitivity cardiac troponin T assay in unstable angina and non-ST-segment elevation myocardial infarction: a pilot study. Arch Cardiovasc Dis 2011 Jan;104(1):4-10.
11. Karakas M, Januzzi JL Jr, Meyer J, et al. Copeptin does not add diagnostic information to high-sensitivity troponin T in low- to intermediate-risk patients with acute chest pain: results from the rule out myocardial infarction by computed tomography (ROMI-CAT) study. Clin Chem 2011 Aug;57(8):1137-45.
12. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009; Aug 27;361(9):868-77.
13. Morrow DA, Cannon CP, Jesse RL, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 2007 Apr;53(4):552-74.
14. Sabatine MS, Morrow DA, de Lemos JA, Jarolim P, Braunwald E. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J 2009 Jan;30(2):162-9.
15. Wu AHB, Lu QA, Todd J, Moecks J, Wians F. Short- and longterm biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem 2009 Nov;55:52-8.
16. Khan SQ, Dhillon OS, O'Brien RJ, et al. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation 2007 Apr 24;115(16):2103-10.
17. Robertson GL. Antidiuretic hormone. Normal and disordered function. Endocrinol Metab Clin North Am 2001 Sep;30(3):671-94, vii.
18. Robertson GL, Athar S. The interaction of blood osmolality and blood volume in regulating plasma vasopressin in man. J Clin Endocrinol Metab 1976 Apr;42(4):613-20.
19. Katan M, Morgenthaler N, Widmer I, et al. Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level. Neuro Endocrinol Lett 2008 Jun;29(3): 341-6.
20. Müller B, Morgenthaler N, Stolz D, et al. Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. Eur J Clin Invest 2007 Feb;37(2):145-52.
21. Morgenthaler NG, Müller B, Struck J, Bergmann A, Redl H, Christ-Crain M. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 2007 Aug;28(2):219-26.
22. Katan M, Fluri F, Morgenthaler NG, et al. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol 2009 Dec;66(6):799-808.